The Mediating Role of Death Anxiety in Hemodialysis Patients

NCT ID: NCT06478446

Last Updated: 2024-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

203 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-02

Study Completion Date

2024-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to determine the mediating role of death anxiety in the relationship between religious attitudes and spiritual care needs of hemodialysis (HD) patients in Turkey. The research was designed as a descriptive and cross-sectional study. A total of 203 patients were included in the study. Descriptive Characteristics Form, Religious Attitude Scale (RAS), Spiritual Care Needs Scale (SCNS), and Death Anxiety Scale (DAS) were used for data collection. In this study, it was found that the indirect effect of religious attitudes on spiritual care needs was significant, and death anxiety mediated the relationship between religious attitudes and spiritual care needs (b= -1.754, 95% CI \[-2.95, -0.65\]). It can be concluded that death anxiety in HD patients directs individuals towards religious attitudes, and in this case, the need for spiritual care increases. In other words, death anxiety mediates the relationship between religious attitudes and spiritual care needs. Therefore, nurses should include spiritual care when providing nursing care for HD patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Materials and Methods The research was designed as a descriptive and cross-sectional study. Population and Sample The population of the study consisted of patients undergoing hemodialysis treatment at Necmettin Erbakan University Medical Faculty Hospital.

Sample The data of Burucu and Cantekin (2022) were used to determine the sample size. In this study, it was reported that death anxiety in dialysis patients varied according to the type of dialysis. In the mentioned study, R2 was 0.062. According to the multiple regression results on death anxiety, it was determined that the study should be completed with at least 149 participants to achieve 80% power and an effect size of 0.066. According to Dunson and Bollen, Structural Equation Modeling can be adequately performed with small sample sizes (approximately 100). However, it is recommended that the sample size should be 200 or more. Therefore, the calculated number was increased by 35% in line with the literature and the sample size of the study was determined as 201. A total of 203 patients were included in the study.

Data Collection Tools Descriptive Characteristics Form, Religious Attitude Scale (RAS), Spiritual Care Needs Scale (SCNS), and Death Anxiety Scale (DAS) were used for data collection.

Data were collected face-to-face by the researchers in the hemodialysis (HD) unit. During data collection, protective measures were taken to prevent the risk of infection. The patients were informed about the study and their consent was obtained.

Ethical approval was obtained from the XXX University Health Sciences Scientific Research Ethics Committee, and necessary permissions were obtained from XXX University Medical Faculty Hospital. All stages of the study were completed in accordance with the STROBE checklist and the Declaration of Helsinki.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis Complication Death Anxiety Religious Stigmata

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observation

HD patients were observed and evaluated with three scales.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being eighteen years of age or older
* Being a resident in Turkey
* To be continuing HD treatment
* Not having communication barriers

Exclusion Criteria

* Non-Muslim individuals,
* Those who are in the last stage of the disease,
* Those undergoing cancer treatment
* Those with cognitive impairment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Necmettin Erbakan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rukiye Burucu

Associate prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Necmettin Erbakan University

Konya, Meram, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NECMETTİN EU-

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.